Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alnylam Pharmaceuticals
Pharma
Alnylam hits profitability in Q4 despite Amvuttra revenue miss
Alnylam shares have dropped about 19% in the past month, more than erasing their gains since the company's first ATTR-CM launch report in July.
Angus Liu
Feb 12, 2026 11:05am
Alnylam recruits dancer with rare disease for Givlaari promo
May 28, 2025 2:04pm
Market growth will help spark sales of Amvuttra, Alnylam says
Feb 13, 2025 2:08pm
Novo, Lilly lost value in Q3 while BMS, Gilead and Sanofi surged
Nov 8, 2024 5:00am
Experts paint tough path ahead of Alnylam's key ATTR-CM readout
Apr 22, 2024 10:55am
Alnylam embarks on campaign to drive hATTR amyloidosis diagnoses
Mar 13, 2024 10:30am
